Skip to main content

 

Main menu

  • Home
  • Articles
    • Current Issue
    • Archive
    • Editorials
    • Immunology Education
    • Most Read
    • On The Horizon Collection
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Services
    • Email Alerts
    • RSS Feeds
  • More
    • AAI Disclaimer
    • Feedback
  • Other Publications
    • American Association of Immunologists
    • The Journal of Immunology

User menu

  • Log in

Search

  • Advanced search
ImmunoHorizons
  • Other Publications
    • American Association of Immunologists
    • The Journal of Immunology
  • Log in
ImmunoHorizons

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Archive
    • Editorials
    • Immunology Education
    • Most Read
    • On The Horizon Collection
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Services
    • Email Alerts
    • RSS Feeds
  • More
    • AAI Disclaimer
    • Feedback
  • Follow ImmunoHorizons on Twitter
  • Follow ImmunoHorizons on RSS
Open Access

Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants

David J. Dowling
ImmunoHorizons July 1, 2018, 2 (6) 185-197; DOI: https://doi.org/10.4049/immunohorizons.1700063
David J. Dowling
Division of Infectious Diseases, Department of Medicine, Boston Children’s Hospital and Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 2 no. 6 185-197
DOI 
https://doi.org/10.4049/immunohorizons.1700063
PubMed 
31022686

Published By 
The American Association of Immunologists, Inc.
Online ISSN 
2573-7732
History 
  • Received December 18, 2017
  • Accepted June 8, 2018
  • Published online July 2, 2018.

Copyright & Usage 
Copyright © 2018 The Authors This article is distributed under the terms of the CC BY-NC 4.0 Unported license.

Author Information

  1. David J. Dowling
  1. Division of Infectious Diseases, Department of Medicine, Boston Children’s Hospital and Harvard Medical School, Boston, MA 02115
  1. Address correspondence and reprint requests to:
    Dr. David J. Dowling, Division of Infectious Diseases, Enders Research Laboratories, Room 730, Boston Children’s Hospital, 300 Longwood Avenue, Boston, MA 02115. E-mail address: david.dowling{at}childrens.harvard.edu
View Full Text

Article usage

Article usage: July 2018 to June 2022

AbstractFullPdf
Jul 20180597124
Aug 20181561150
Sep 2018024180
Oct 2018032582
Nov 2018032286
Dec 2018029476
Total 201812340598
Jan 201910351105
Feb 20193539790
Mar 2019112437115
Apr 2019141506117
May 2019110711111
Jun 201966826118
Jul 2019152788101
Aug 201928078095
Sep 2019277598104
Oct 2019269601108
Nov 201917650297
Dec 201910841981
Total 2019173669161242
Jan 20204597152
Feb 202010423158
Mar 20203379112
Apr 20205400120
May 20201367125
Jun 20202294109
Jul 2020433589
Aug 20206284103
Sep 2020626872
Oct 2020125672
Nov 2020725188
Dec 2020322663
Total 20205240801263
Jan 2021224267
Feb 2021425683
Mar 20210271100
Apr 20213278105
May 2021127197
Jun 2021526998
Jul 2021114874
Aug 2021126047
Sep 2021229856
Oct 2021115970
Nov 2021218367
Dec 2021015856
Total 2021222793920
Jan 2022119562
Feb 2022214759
Mar 2022117377
Apr 2022015947
May 2022314668
Jun 20222113666
Total 202228956379
Total1839170854402

PreviousNext
Back to top

In this issue

ImmunoHorizons: 2 (6)
ImmunoHorizons
Vol. 2, Issue 6
1 Jul 2018
  • Table of Contents
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about ImmunoHorizons.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants
(Your Name) has forwarded a page to you from ImmunoHorizons
(Your Name) thought you would like to see this page from the ImmunoHorizons web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants
David J. Dowling
ImmunoHorizons July 1, 2018, 2 (6) 185-197; DOI: 10.4049/immunohorizons.1700063

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants
David J. Dowling
ImmunoHorizons July 1, 2018, 2 (6) 185-197; DOI: 10.4049/immunohorizons.1700063
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • TLR7 AND TLR8
    • FORMULATION MATTERS: UNLEASHING TLR7/8 ADJUVANTICITY
    • AGE-SPECIFIC TLR7/8 ADJUVANTICITY IN EARLY LIFE
    • TLR8: A SENSOR FOR BACTERIAL RNA
    • CONCLUSIONS
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • An Analysis of Factors That Influence Students to Pursue Immunology
  • Toward a Paradigm to Distinguish Distinct Functions of FOXP3+ Regulatory T Cells
  • Granzyme-Producing CD4 T Cells in Cancer and Autoimmune Disease
Show more ON THE HORIZON

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds

Copyright© 2022 by The American Association of Immunologists, Inc

Online ISSN 2573-7732